Group
Percent of graft cells that co-labeled for these markers (mean% ± SD)
Nestin
MAP2
GFAP
KI67
Injection
74% (± 38)
19% (± 40)
0%
18% (± 17)
Injection+oral
56% (± 43)
12% (± 20)
0%
18% (± 11)
Oral
87%
0%
0%
23%
Control
48% (± 50)
0%
0%
9% (± 8)
Table 2:
Graft cell differentiation.